To continue reading this article, sign up for FREE to
Membership is FREE
and provides you with
instant access
to email newsletters, digital publications, our full content catalogue & more...
Companies Combine to Form Ion Channel Consortium
Together, the three companies will offer value added identification and validation of ion channel modulators. The Ion Channel Consortium combines Alion’s proprietary method for short-listing drug candidates, Specs’ reliable sourcing and synthesis of compounds, and Aurora’s patch clamp services.
Researchers now have an option that enables time and cost savings while providing a unique method to identify new drug candidates for channelopathies.
Add Technology Networks as a preferred Google source to see more of our trusted coverage.
